PHARMACYTE BIOTECH INC's ticker is and the CUSIP is 71715X903. A total of 3 filers reported holding PHARMACYTE BIOTECH INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,500 | -26.6% | 5,000 | 0.0% | 0.00% | – |
| Q2 2023 | $14,300 | +4814.1% | 5,000 | +4900.0% | 0.00% | – |
| Q1 2023 | $291 | -99.3% | 100 | -99.3% | 0.00% | – |
| Q4 2022 | $42,632 | +21.8% | 14,600 | +0.7% | 0.00% | – |
| Q3 2022 | $35,000 | +400.0% | 14,500 | +383.3% | 0.00% | – |
| Q2 2022 | $7,000 | -88.1% | 3,000 | -87.2% | 0.00% | – |
| Q4 2021 | $59,000 | -16.9% | 23,400 | +4.0% | 0.00% | – |
| Q3 2021 | $71,000 | – | 22,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $291 | 0.00% |
| SIMPLEX TRADING, LLC | 100 | $0 | 0.00% |